184 related articles for article (PubMed ID: 32413384)
1. Signaling through estrogen receptors modulates long non-coding RNAs in prostate cancer.
Nanni S; Bacci L; Aiello A; Re A; Salis C; Grassi C; Pontecorvi A; Gaetano C; Farsetti A
Mol Cell Endocrinol; 2020 Jul; 511():110864. PubMed ID: 32413384
[TBL] [Abstract][Full Text] [Related]
2. MALAT1 and HOTAIR Long Non-Coding RNAs Play Opposite Role in Estrogen-Mediated Transcriptional Regulation in Prostate Cancer Cells.
Aiello A; Bacci L; Re A; Ripoli C; Pierconti F; Pinto F; Masetti R; Grassi C; Gaetano C; Bassi PF; Pontecorvi A; Nanni S; Farsetti A
Sci Rep; 2016 Dec; 6():38414. PubMed ID: 27922078
[TBL] [Abstract][Full Text] [Related]
3. [Long non-coding RNAs related to androgen receptor function in prostate cancer: Advances in studies].
Wang M; Ying J; Zhang M; Liang CZ
Zhonghua Nan Ke Xue; 2019 Aug; 25(8):739-743. PubMed ID: 32227719
[TBL] [Abstract][Full Text] [Related]
4. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
[TBL] [Abstract][Full Text] [Related]
5. Role of lncRNAs in prostate cancer development and progression.
Weiss M; Plass C; Gerhauser C
Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
[TBL] [Abstract][Full Text] [Related]
6. [Roles of long non-coding RNAs in prostate cancer and their action mechanisms].
Li ZF; Xiao N; Yao YW; Yao ZF
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1129-1135. PubMed ID: 37846635
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Das R; Feng FY; Selth LA
Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
[TBL] [Abstract][Full Text] [Related]
8. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
9. LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.
Yao M; Shi X; Li Y; Xiao Y; Butler W; Huang Y; Du L; Wu T; Bian X; Shi G; Ye D; Fu G; Wang J; Ren S
Cell Death Dis; 2020 Aug; 11(8):638. PubMed ID: 32801300
[TBL] [Abstract][Full Text] [Related]
10. H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer.
Bacci L; Aiello A; Ripoli C; Loria R; Pugliese D; Pierconti F; Rotili D; Strigari L; Pinto F; Bassi PF; Mai A; Grassi C; Pontecorvi A; Falcioni R; Farsetti A; Nanni S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426484
[TBL] [Abstract][Full Text] [Related]
11. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management.
Ramnarine VR; Kobelev M; Gibb EA; Nouri M; Lin D; Wang Y; Buttyan R; Davicioni E; Zoubeidi A; Collins CC
Eur Urol; 2019 Nov; 76(5):546-559. PubMed ID: 31445843
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
13. Role of Long Noncoding RNAs in Neoplasia: Special Emphasis on Prostate Cancer.
Alahari SV; Eastlack SC; Alahari SK
Int Rev Cell Mol Biol; 2016; 324():229-54. PubMed ID: 27017010
[TBL] [Abstract][Full Text] [Related]
14. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
Chakravarty D; Sboner A; Nair SS; Giannopoulou E; Li R; Hennig S; Mosquera JM; Pauwels J; Park K; Kossai M; MacDonald TY; Fontugne J; Erho N; Vergara IA; Ghadessi M; Davicioni E; Jenkins RB; Palanisamy N; Chen Z; Nakagawa S; Hirose T; Bander NH; Beltran H; Fox AH; Elemento O; Rubin MA
Nat Commun; 2014 Nov; 5():5383. PubMed ID: 25415230
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs and prostate cancer.
Misawa A; Takayama KI; Inoue S
Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
[TBL] [Abstract][Full Text] [Related]
16. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer.
Chang YT; Lin TP; Tang JT; Campbell M; Luo YL; Lu SY; Yang CP; Cheng TY; Chang CH; Liu TT; Lin CH; Kung HJ; Pan CC; Chang PC
Cancer Lett; 2018 Oct; 433():43-52. PubMed ID: 29944905
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
[TBL] [Abstract][Full Text] [Related]
18. [Long non-coding RNAs in prostate cancer: An update].
Wu PG; Zhang YX
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
[TBL] [Abstract][Full Text] [Related]
19. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y
Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
Xu YH; Deng JL; Wang G; Zhu YS
Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
